Shenzhen New Industries Biomedical Engineering Co., Ltd. (300832) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Shenzhen New Industries Biomedical Engineering Co., Ltd.

Why is Shenzhen New Industries Biomedical Engineering Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of 15.95% and Operating profit at 14.38% over the last 5 years

Negative results in Sep 25

INTEREST(HY) At CNY 0.33 MM has Grown at 44.26%
ROCE(HY) Lowest at 19.56%
DEBT-EQUITY RATIO (HY) Highest at -25.8 %

Below par performance in long term as well as near term

Along with generating -19.77% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Shenzhen New Industries Biomedical Engineering Co., Ltd. for you?

Medium Risk, Low Return

Absolute

Risk Adjusted

Volatility

Shenzhen New Industries Biomedical Engineering Co., Ltd.

-19.77%

-1.16

29.91%

China Shanghai Composite

13.33%

0.90

14.74%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

15.95%

EBIT Growth (5y)

14.38%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.28

Sales to Capital Employed (avg)

0.53

Tax Ratio

12.50%

Dividend Payout Ratio

55.86%

Pledged Shares

Institutional Holding

ROCE (avg)

40.76%

ROE (avg)

19.99%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

6.46

EV to EBIT

29.85

EV to EBITDA

26.35

EV to Capital Employed

7.95

EV to Sales

11.51

PEG Ratio

Dividend Yield

1.90%

ROCE (Latest)

26.62%

ROE (Latest)

20.16%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bearish

OBV

No Trend

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

3What is working for the Company

RAW MATERIAL COST(Y)

Fallen by -0.84% (YoY

INVENTORY TURNOVER RATIO(HY)

Highest at 1.51 times

NET SALES(Q)

Highest at CNY 1,242.79 MM

-15What is not working for the Company

INTEREST(HY)

At CNY 0.33 MM has Grown at 44.26%

ROCE(HY)

Lowest at 19.56%

DEBT-EQUITY RATIO (HY)

Highest at -25.8 %

INTEREST COVERAGE RATIO(Q)

Lowest at 246,606.97

CASH AND EQV(HY)

Lowest at CNY 4,040.93 MM

Here's what is working for Shenzhen New Industries Biomedical Engineering Co., Ltd.

Net Sales

Highest at CNY 1,242.79 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Inventory Turnover Ratio

Highest at 1.51 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Raw Material Cost

Fallen by -0.84% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Shenzhen New Industries Biomedical Engineering Co., Ltd.

Interest

At CNY 0.33 MM has Grown at 44.26%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Interest Coverage Ratio

Lowest at 246,606.97

in the last five periods

MOJO Watch

The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Debt-Equity Ratio

Highest at -25.8 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Cash and Eqv

Lowest at CNY 4,040.93 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents